Ansa Biotechnologies, Inc.

📍 Emeryville, United States🗓 Founded 2018👥 89 employees💰 Last funded 2023
Biotechnology Research🌐 ansabio.com
Website LinkedIn
At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.
5
Total investors
3
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
4
Hong Kong SAR
1
Investor activity2018–2023 · investors recorded per year
20181202022022120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ansa Biotechnologies, Inc.?
Ansa Biotechnologies, Inc. has 5 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage.
When did Ansa Biotechnologies, Inc. last raise funding?
The most recent investment in Ansa Biotechnologies, Inc. recorded on gritt.io was in 2023.
When was Ansa Biotechnologies, Inc. founded?
Ansa Biotechnologies, Inc. was founded in 2018.
What industry is Ansa Biotechnologies, Inc. in?
Ansa Biotechnologies, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ansa Biotechnologies, Inc. based?
Ansa Biotechnologies, Inc. is headquartered in Emeryville, United States.